24Serious

Shakhriyar Mamedyarov

Shakhriyar Mamedyarov

Ask VT AI

View News Summary

Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Two U.S. Navy aircraft crash in the South China Sea, prompting rescue efforts and investigations amid geopolitical tensions.
Russia tests nuclear-powered cruise missile, raising concerns over technical challenges and strategic implications.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Latest News

Shakhriyar Mamedyarov

Gukesh and Ding Liren Level in Chess Championship

100% left coverage1 source

Shakhriyar Mamedyarov

Gukesh and Ding Liren Level in Chess Championship

100% left coverage1 source

Gukesh and Ding Liren Level in Chess Championship

Gukesh and Ding Liren Level in Chess Championship

Shakhriyar Mamedyarov

Strong Start at 45th Chess Olympiad

100% right coverage1 source

Shakhriyar Mamedyarov

Strong Start at 45th Chess Olympiad

100% right coverage1 source

Strong Start at 45th Chess Olympiad

Strong Start at 45th Chess Olympiad

Shakhriyar Mamedyarov

India's Chess Teams Shine at Budapest Olympiad

100% right coverage1 source

Shakhriyar Mamedyarov

India's Chess Teams Shine at Budapest Olympiad

100% right coverage1 source

India's Chess Teams Shine at Budapest Olympiad

India's Chess Teams Shine at Budapest Olympiad

Ask VT AI

View News Summary

Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Two U.S. Navy aircraft crash in the South China Sea, prompting rescue efforts and investigations amid geopolitical tensions.
Russia tests nuclear-powered cruise missile, raising concerns over technical challenges and strategic implications.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Shakhriyar Mamedyarov